Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease

被引：0
|
作者：
Cédric Fontaine-Sylvestre
Laurent Létourneau-Guillon
Robert A. Moumdjian
France Berthelet
André Lacroix
机构：
[1] Université de Montréal,Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal (CHUM)
[2] Université de Montréal,Neuroradiology Division, Department of Radiology, Centre hospitalier de l’Université de Montréal (CHUM)
[3] Université de Montréal,Neurosurgery Division, Department of Surgery, Centre hospitalier de l’Université de Montréal (CHUM)
[4] Université de Montréal,Neuropathology Division, Department of Pathology, Centre hospitalier de l’Université de Montréal (CHUM)
来源：
Pituitary | 2021年 / 24卷
关键词：
Corticotroph tumor progression; Nelson’s syndrome; Cushing’s disease; Osilodrostat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：207 / 215
页数：8
相关论文
共 50 条
  • [1] Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing's disease
    Fontaine-Sylvestre, Cedric
    Letourneau-Guillon, Laurent
    Moumdjian, Robert A.
    Berthelet, France
    Lacroix, Andre
    [J]. PITUITARY, 2021, 24 (02) : 207 - 215
  • [2] Progression of a corticotroph tumour during durable medical therapy with osilodrostat in a patient with persistent Cushing's disease
    Borawski, Bartlomiej
    Wojciechowska-Luzniak, Agnieszka
    Zielinski, Grzegorz
    Witek, Przemyslaw
    [J]. ENDOKRYNOLOGIA POLSKA, 2023, 74 (03) : 346 - 347
  • [3] Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension
    Fleseriu, Maria
    Newell-Price, John
    Pivonello, Rosario
    Shimatsu, Akira
    Auchus, Richard J.
    Scaroni, Carla
    Belaya, Zhanna
    Feelders, Richard A.
    Vila, Greisa
    Houde, Ghislaine
    Walia, Rama
    Izquierdo, Miguel
    Roughton, Michael
    Pedroncelli, Alberto M.
    Biller, Beverly M. K.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 187 (04) : 531 - 541
  • [4] Cushing's Disease: Long-Term Effectiveness and Safety of Osilodrostat in a Polish Group of Patients with Persistent Hypercortisolemia in the Experience of a Single Center
    Dzialach, Lukasz
    Sobolewska, Joanna
    Respondek, Wioleta
    Szamotulska, Katarzyna
    Witek, Przemyslaw
    [J]. BIOMEDICINES, 2023, 11 (12)
  • [5] Corticotroph tumor progression after adrenalectomy in Cushing's disease:: A reappraisal of Nelson's syndrome
    Assie, Guillaume
    Bahurel, Helene
    Coste, Joel
    Silvera, Stephane
    Kujas, Michele
    Dugue, Marie-Annick
    Karray, Foued
    Dousset, Bertrand
    Bertherat, Jerome
    Legmann, Paul
    Bertagna, Xavier
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01): : 172 - 179
  • [6] Changes in Plasma ACTH Levels and Corticotroph Tumor Size in Patients With Cushing's Disease During Long-term Treatment With the Glucocorticoid Receptor Antagonist Mifepristone
    Fleseriu, Maria
    Findling, James W.
    Koch, Christian A.
    Schlaffer, Sven-Martin
    Buchfelder, Michael
    Gross, Coleman
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10): : 3718 - 3727
  • [7] Failure of long-term therapy with sodium valproate in Cushing’s disease
    Annamaria Colao
    R. Pivonello
    F. S. Tripodi
    F. Orio
    D. Ferone
    G. Cerbone
    C. Di Somma
    B. Merola
    G. Lombardi
    [J]. Journal of Endocrinological Investigation, 1997, 20 : 387 - 392
  • [8] Failure of long-term therapy with sodium valproate in Cushing's disease
    Colao, A
    Pivonello, R
    Tripodi, FS
    Orio, F
    Ferone, D
    Cerbone, G
    DiSomma, C
    Merola, B
    Lombardi, G
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (07) : 387 - 392
  • [9] Osilodrostat-induced adrenal insufficiency in a patient with Cushing's disease
    Ekladios, Catherine
    Khoury, Jessica
    Mehr, Shahzad
    Feghali, Krystel
    [J]. CLINICAL CASE REPORTS, 2022, 10 (11):
  • [10] New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
    Maria Fleseriu
    Stephan Petersenn
    [J]. Journal of Neuro-Oncology, 2013, 114 : 1 - 11
12345